chr10-18515022-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The ENST00000352115.10(CACNB2):​c.713G>A​(p.Gly238Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000525 in 1,613,692 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00029 ( 4 hom. )

Consequence

CACNB2
ENST00000352115.10 missense

Scores

15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.74

Publications

4 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007593423).
BP6
Variant 10-18515022-G-A is Benign according to our data. Variant chr10-18515022-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 191568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 417 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000352115.10. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.804+653G>A
intron
N/ANP_963890.2
CACNB2
NM_201590.3
MANE Plus Clinical
c.642+653G>A
intron
N/ANP_963884.2
CACNB2
NM_201597.3
c.713G>Ap.Gly238Asp
missense
Exon 7 of 14NP_963891.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000352115.10
TSL:1
c.713G>Ap.Gly238Asp
missense
Exon 7 of 14ENSP00000344474.6
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.804+653G>A
intron
N/AENSP00000320025.8
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.642+653G>A
intron
N/AENSP00000366546.4

Frequencies

GnomAD3 genomes
AF:
0.00274
AC:
417
AN:
152136
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00958
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000753
AC:
189
AN:
251154
AF XY:
0.000354
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000294
AC:
430
AN:
1461438
Hom.:
4
Cov.:
30
AF XY:
0.000238
AC XY:
173
AN XY:
727060
show subpopulations
African (AFR)
AF:
0.00986
AC:
330
AN:
33462
American (AMR)
AF:
0.000470
AC:
21
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000279
AC:
31
AN:
1111674
Other (OTH)
AF:
0.000762
AC:
46
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
23
47
70
94
117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00274
AC:
417
AN:
152254
Hom.:
3
Cov.:
33
AF XY:
0.00249
AC XY:
185
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00955
AC:
397
AN:
41552
American (AMR)
AF:
0.000981
AC:
15
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68010
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000681
Hom.:
0
Bravo
AF:
0.00331
ESP6500AA
AF:
0.0116
AC:
51
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000906
AC:
110
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Brugada syndrome 4 Benign:1
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
22
DANN
Benign
0.83
DEOGEN2
Benign
0.0097
T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.049
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.53
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-0.69
T
PhyloP100
1.7
PROVEAN
Benign
-0.030
N
REVEL
Benign
0.27
Sift
Benign
0.62
T
Sift4G
Benign
0.36
T
Polyphen
0.0
B
Vest4
0.15
MVP
0.69
ClinPred
0.011
T
GERP RS
4.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142899184; hg19: chr10-18803951; API